127 related articles for article (PubMed ID: 7521195)
1. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.
Hasegawa Y; Nakano S; Sobue T; Fujita M; Ishiguro S; Sasaki Y; Imaoka S; Tanaka S; Kasugai H; Inoue A
Ann Nucl Med; 1994 May; 8(2):139-45. PubMed ID: 7521195
[TBL] [Abstract][Full Text] [Related]
2. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H
Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674
[TBL] [Abstract][Full Text] [Related]
3. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H
J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910
[TBL] [Abstract][Full Text] [Related]
4. Small hepatocellular carcinoma visualized with technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan.
Narabayashi I; Hamada T; Aoki O; Suematsu T
Ann Nucl Med; 1987 Sep; 1(1):39-42. PubMed ID: 2856317
[TBL] [Abstract][Full Text] [Related]
5. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
6. A hepatobiliary study with Tc-99m N-pyridoxyl-5-methyltryptophan (PMT) in a patient with hepatoblastoma.
Ohshiro K; Hanashiro Y; Shimabukuro K; Hori A; Nagata Y; Matsumoto H; Uchima H
Clin Nucl Med; 1991 Jan; 16(1):10-2. PubMed ID: 1847848
[TBL] [Abstract][Full Text] [Related]
7. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
Kashiwagi T; Azuma M; Matsuda H; Yoshioka H; Ishizu H; Mitsutani N; Koizumi T; Kobayashi Y
Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2061-7. PubMed ID: 2419606
[No Abstract] [Full Text] [Related]
9. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma].
Wu ZM
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):360-3. PubMed ID: 2854779
[TBL] [Abstract][Full Text] [Related]
10. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.
Hasegawa Y; Nakano S; Ishiguro S; Imaoka S; Sasaki Y; Tanaka S; Kasugai H; Kojima J; Ishigami S
Eur J Nucl Med; 1988; 14(7-8):414-8. PubMed ID: 2846309
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma].
Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S
Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071
[No Abstract] [Full Text] [Related]
12. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma].
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Kasugai H; Tanaka S; Inoue A; Kojima J; Fujita M
Kaku Igaku; 1992 Mar; 29(3):367-76. PubMed ID: 1316500
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses.
Oyamada H; Yamazaki S; Makuuchi M; Hasegawa H
Radioisotopes; 1989 May; 38(5):244-51. PubMed ID: 2546192
[TBL] [Abstract][Full Text] [Related]
15. Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Tanaka S; Kasugai H; Okano Y
Eur J Nucl Med; 1985; 10(5-6):255-8. PubMed ID: 2985390
[TBL] [Abstract][Full Text] [Related]
16. Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma.
Sueyoshi K; Narabayashi I; Aratani T; Doi K; Komori T; Ogura Y; Utsunomiya K; Shimidzu T
Clin Nucl Med; 2001 Mar; 26(3):221-4. PubMed ID: 11245114
[TBL] [Abstract][Full Text] [Related]
17. [Radionuclear estimation with 99mTc-N-pyridoxyl-5-methyl-tryptophan (PMT) scintigraphy of recurrent hepatocellular carcinoma after non-surgical treatment].
Matsumoto H; Matsuura M; Sakurai H; Nakajima N; Ito K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Oct; 57(12):805-11. PubMed ID: 9394570
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m PMT whole-body scintigraphy for evaluated of therapeutic effect and for monitoring bone metastasis in a patient with hepatocellular carcinoma.
Sueyoshi K; Narabayashi I; Doi K; Takahashi M; Komori T; Tatsu Y; Tatsumi T; Utunomiya K; Uesugi Y; Adachi I; Shimizu T
Clin Nucl Med; 2000 Dec; 25(12):1000-3. PubMed ID: 11129132
[TBL] [Abstract][Full Text] [Related]
19. Extraosseous metastases of hepatocellular carcinoma detection and therapeutic assessment with Tc-99m PMT SPECT.
Hayase N; Fukumoto M; Yoshida D; Kariya S; Akagi N; Kurohara A; Hisa N; Yoshida S
Clin Nucl Med; 1999 May; 24(5):326-9. PubMed ID: 10232470
[TBL] [Abstract][Full Text] [Related]
20. A new synthetic method for 99mTc labeled N-pyridoxyl-5-methyltryptophan as a hepatoma imaging agent.
Zhou YG; Zhu T; Zhao HY; Wu ZM; Shi QX; Liang FH
Int J Rad Appl Instrum B; 1987; 14(5):467-73. PubMed ID: 2822632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
